The Scientist | Elizabeth Cormier-May In this contributed article for The Scientist, Mammogen Co-Founder and CEO Elizabeth Cormier-May explores why RNA may represent the next frontier in molecular diagnostics. The article examines how RNA can provide a dynamic view of what is happening biologically in real time, and why that information may be particularly valuable in early cancer detection. Cormier-May also discusses the importance of moving beyond simply detecting disease earlier toward generating insights that can meaningfully inform clinical decisions and patient care. Read the full article on The Scientist →